Price $15.01 |
Market Cap
199.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-11.7K
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-
|
ROI
-78.30%
|
|
ROA
-
|
EPS Growth
-
|
Current Ratio
5.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Senomyx Inc. (SNMX) | $1.08 | - | - | 58.4M | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $15.74 | - | - | 40.1M | Strong Buy |
| Acorda Therapeutics Inc (ACOR) | $30.00 | - | - | 1.32B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $23.30 | - | 3.50% | 24.52B | Strong Buy |
| Valeant Pharmaceuticals Intl I (VRX) | $23.40 | - | - | 7.98B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
